Medicus Pharma Ltd. Common Stock

MDCX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$11,156-$5,315-$1,692-$2,055
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$713$99$0$0
Change in WC$33$473-$79-$7
Other Non-Cash$162$585$714$614
Operating Cash Flow-$10,247-$4,158-$1,057-$1,448
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$5,173$500$1,246$882
Stock Issued$7,520$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$5,110$0$0
Financing Cash Flow$12,692$5,610$1,246$882
Forex Effect$0$0$0$0
Net Chg. in Cash$2,445$1,452$189-$566
Supplemental Information
Beg. Cash$1,719$268$79$644
End Cash$4,164$1,719$268$79
Free Cash Flow-$10,247-$4,158-$1,057-$1,448
Medicus Pharma Ltd. Common Stock (MDCX) Financial Statements & Key Stats | AlphaPilot